Key result
Children with ventricular septal defect and 25-hydroxyvitamin D deficiency had a 24.0-fold higher prevalence of pulmonary hypertension (p<0.01).
Why the study?
Children with CHD have significantly lower 25-hydroxyvitamin D levels, but its correlation with pulmonary hypertension in children with ventricular septal defect required investigation.
Is low serum 25-hydroxyvitamin D level associated with an increased risk of pulmonary hypertension in children with ventricular septal defect?
Cross-Sectional (n=44)
Is low serum 25-hydroxyvitamin D level associated with an increased risk of pulmonary hypertension in children with ventricular septal defect?
Answers are grounded in this paper and cite their sources.
In children with ventricular septal defect, 25-hydroxyvitamin D deficiency is strongly associated with the presence of pulmonary hypertension.
INTRODUCTION: Ventricular septal defect is the most common CHD, leading to pulmonary hypertension. Significantly lower 25-hydroxyvitamin D level was reported in children with CHD compared with healthy controls. The current study aimed to investigate the correlation between 25-hydroxyvitamin D level and pulmonary hypertension in children with ventricular septal defect. METHODS: A cross-sectional study was conducted on ventricular septal defect paediatric patients from January to June, 2019. Serum 25-hydroxyvitamin D was measured using electrochemiluminescence. Pulmonary hypertension was defined as mean pulmonary artery systolic pressure > 20 mmHg for children >3 months of age at sea level, measured by Doppler echocardiography. RESULTS: From forty-four subjects, the majority of the subjects were female (56.8%) with normal nutritional status and perimembranous ventricular septal defect. Bivariate analysis showed that 25-hydroxyvitamin D level was associated with pulmonary hypertension (p < 0.01), type and size of ventricular septal defect (p = 0.02), and heart failure (p < 0.01). Higher 25-hydroxyvitamin D level was correlated with better nutritional status (p = 0.04, r = 0.26), and lower 25-hydroxyvitamin D level was correlated with the occurence of perimembranous ventricular septal defect (p = 0.01, r = -0.39), larger defect size (p < 0.01, r = -0.70), history of pneumonia (p = 0.02, r = -0.31), and heart failure (p < 0.01, r = -0.64). Subjects with 25-hydroxyvitamin D deficiency had prevalence ratio of 24.0 times for pulmonary hypertension. Higher pulmonary artery pressure was correlated to the occurence perimembranous ventricular septal defect (p = 0.01, r = 0.47), larger defect size (p < 0.01, r = 0.78), history of pneumonia (p = 0.01, r = 0.38), and heart failure (p < 0.01, r = 0.75). CONCLUSION: Children with ventricular septal defect who had low 25-hydroxyvitamin D level posed a higher risk of having pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cross-sectional in Ventricular septal defect (n=44). 25-hydroxyvitamin D deficiency vs. Normal/higher 25-hydroxyvitamin D levels was evaluated on Pulmonary hypertension (PR 24.0, p=<0.01). Children with ventricular septal defect and 25-hydroxyvitamin D deficiency had a 24.0-fold higher prevalence of pulmonary hypertension (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: